SAMANTHA REYNOLDS: Open Payments
NPI 1477065498 · BIRMINGHAM, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$402 in 4 payments from 3 companies in 2025. Trend: 2023 $37 · 2024 $740 · 2025 $402
Food & beverage: $402
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 2 | $158 |
| Otsuka America Pharmaceutical, Inc. | 1 | $122 |
| Novo Nordisk Inc | 1 | $122 |
Products named: INGREZZA, REXULTI.
Industry payments across AL — which companies pay providers there.
